Activity Preview

Live

Activity 2 (SET2019_QC)

Activity Type:

  • On Demand


Release Date: 5/1/2019

Expiration Date: 5/31/2019

  • AMA PRA Category 1 Physician: 50
  • Participation: 50

Access Activity

Overview

This activity is a credit claim mechanism for individuals who've completed the paper-based workbook, FOCUS Psychiatry Review: Volume 2, DSM-5 Revised Edition

Pricing

Enter the group id code on the Purchase step to unlock the activity, complete the evaluation, and generate a certificate of completion.

For questions or for more information, contact educme@psych.org

Estimated Time to Complete

Estimated Duration: Up to 50 hours
Begin Date: February 2011
Review Date: February 2017
End Date: December 31, 2018

Target Audience

Individuals who wish to claim credit for completing the printed workbook

How to Earn Credit

Individuals should complete the printed workbook and self-score the 400-multiple choice questions provided therein. Individuals can review resource materials prior to answering the questions provided in the workbook, or they can use the workbook to review the references listed in the critiques after scoring test sections. A score of 70% or higher is required to claim credit and users must also submit an evaluation.

Continuing Education Credit

The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this enduring material for a maximum of 50 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty and Planner Disclosures

Disclosure of Financial Interests or Other Affiliations With Commercial Organizations

  • Deborah J. Hales, M.D., Former Director, American Psychiatric Association Division of Education, Arlington, Virginia, No financial affiliations with commercial organizations
  • Mark Hyman Rapaport, M.D., Chairman, Department of  Psychiatry, Emory University Atlanta, No financial affiliations with commercial organizations
  • Robert J. Boland, M.D., Associate Professor of Psychiatry and Human Behavior, Division of Biology and Medicine, Brown University, Providence, Rhode Island, No financial affiliations with commercial organizations
  • J. Michael Bostwick, M.D., Assistant Professor of Psychiatry, Mayo Medical School Consultant, Department of Psychiatry and Psychology, Mayo Clinic and Foundation, Rochester, Minnesota, No financial affiliations with commercial organizations
  • John H. Coverdale, M.D., Associate Professor of Psychiatry and Medical Ethics, Baylor College of Medicine, Houston, Texas, No financial affiliations with commercial organizations
  • Arden D. Dingle, M.D., Associate Professor, Department of Psychiatry and Behavioral Sciences, Training Director, Child and Adolescent Psychiatry, Emory University School of Medicine, Atlanta, Georgia, No financial affiliations with commercial organizations
  • Laura Fochtmann, M.D., Practice Guidelines Medical Editor, American Psychiatric Association, and Professor, Department of Psychiatry and Behavioral Sciences, Department of Pharmacological Sciences, and Department of Emergency Medicine, Stony Brook University, Stony Brook, New York, No financial affiliations with commercial organizations
  • Suzanne Garfinkle, M.D., M.Sc., Fellow in Child and Adolescent Psychiatry, Mount Sinai School of Medicine, New York, New York, No financial affiliations with commercial organizations
  • James W. Jefferson, M.D., Clinical Professor of Psychiatry, University of Wisconsin Medical School, Distinguished Senior Scientist, Madison, Institute of Medicine, Inc., Director, Healthcare Technology Systems, Inc., Madison, Wisconsin, Grant/Research Support: Bristol-Myers Squibb, GlaxoSmithKline,  Lilly, Novartis, Pfizer, Wyeth. Consultant: Glaxo- SmithKline.  Lecture Honoraria: Bristol-Myers Squibb, GlaxoSmithKline,  Lilly, Wyeth Stock Shareholder: Bristol-Myers Squibb, GlaxoSmithKline, SciClone. Principal: Healthcare Technology Systems, Inc.
  • Martin H. Leamon, M.D., Associate Professor of Clinical Psychiatry, University of California-Davis, Sacramento, No financial affiliations with commercial organizations
  • Vishal Madaan, M.D., Director, Child and Adolescent Psychopharmacology, and Staff Child and Adolescent Psychiatrist, Creighton Uni- versity Medical Center, Omaha, Nebraska, No financial affiliations with commercial organizations
  • Annette M. Matthews, M.D., Psychiatrist, Portland Veterans Affairs Medical Center, Portland, Oregon, Assistant Professor of Psychiatry, Oregon, Health and Science University, Portland, Oregon, No financial affiliations with commercial organizations
  • David W. Preven, M.D., Clinical Professor in the Department of Behavioral Sciences and Psychiatry, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, Speaker: Pfizer, Forest
  • Rima Styra, M.D., Toronto General Hospital, University Health Network, Department of Psychiatry, Toronto, Ontario, Canada, No financial affiliations with commercial organizations
  • Lowell D. Tong, M.D., Associate Chair of Education, Department of Psychiatry, University of California San Francisco School of Medicine, No financial affiliations with commercial organizations
  • Marcia L. Verduin, M.D., Associate Professor of Psychiatry, Assistant Dean for Students, University of Central Florida College of Medicine, Orlando, Florida, Grant/Research Support: Robert Wood Johnson Foundation
  • Eric R. Williams, M.D., Assistant Professor of Child and Adolescent Psychiatry, University of South Carolina School of Medicine, Charles- ton, South Carolina, No financial affiliations with commercial organizations
  • Isaac K. Wood, M.D., Associate Professor of Psychiatry and Pediatrics, Associate Dean of Student Activities, Director of Medical Student Education in Psychiatry, Virginia Commonwealth University School of Medicine, Richmond, Virginia, No financial affiliations with commercial organizations
  • Joel Yager, M.D., Professor, Department of Psychiatry, School of Medicine, University of Colorado; Emeritus Professor, Department of Psychiatry at the University of New Mexico School of Medicine and Department of Psychiatry and Biobehavioral Sciences at the the David Geffen School of Medicine at UCLA, No financial affiliations with commercial organizations
  • Kristen Moeller, Editorial Staff FOCUS Psychiatry Review, Director of Continuing Medical Education, American Psychiatric Association, Arlington, Virginia, Reports no competing interests

Disclosure of Unapproved or Investigational Use of a Product

FOCUS examination questions may contain information on off-label uses of particular medications. Off-label use of medications by individual physicians is permitted and common. Decisions about off-label use can be guided by the evidence provided in the scientific literature and by clinical experience.

Hardware/Software Requirements

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration:

  • Flash Player: Adobe Flash Player 10.3+ 
  • Browser: Firefox (latest version), Internet Explorer 8.0+, Safari 7.0+, Microsoft Edge (latest version) or Google Chrome (latest version)
  • Operating System: Windows XP+ or Mac OS X 10.4+ 
  • Internet Connection: 1 Mbps or higher

Minimum Requirements:

  • Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Macromedia Flash Player 10.3 or higher; Sound Card at least 16-bit; audio playback with speakers for programs with video content
  • Macintosh:Mac OS X 10.4+ or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit; audio playback with speakers for programs with video content

For assistance: Contact educme@psych.org for questions about this course | Contact learningcenter@psych.org for technical assistance

Access Activity